192 related articles for article (PubMed ID: 38040679)
1. Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.
Amable L; Ferreira Martins LA; Pierre R; Do Cruseiro M; Chabab G; Sergé A; Kergaravat C; Delord M; Viret C; Jaubert J; Liu C; Karray S; Marie JC; Irla M; Georgiev H; Clave E; Toubert A; Lucas B; Klibi J; Benlagha K
Nat Commun; 2023 Dec; 14(1):7922. PubMed ID: 38040679
[TBL] [Abstract][Full Text] [Related]
2. Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function.
Sundararaj S; Zhang J; Krovi SH; Bedel R; Tuttle KD; Veerapen N; Besra GS; Khandokar Y; Praveena T; Le Nours J; Matsuda JL; Rossjohn J; Gapin L
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1204-E1213. PubMed ID: 29351991
[TBL] [Abstract][Full Text] [Related]
3. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
4. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
Fiedler T; Walter W; Reichert TE; Maeurer MJ
Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
[TBL] [Abstract][Full Text] [Related]
6. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
7. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Stenström M; Sköld M; Andersson A; Cardell SL
Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
[TBL] [Abstract][Full Text] [Related]
8. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice.
Chen YH; Wang B; Chun T; Zhao L; Cardell S; Behar SM; Brenner MB; Wang CR
J Immunol; 1999 Apr; 162(8):4560-6. PubMed ID: 10201995
[TBL] [Abstract][Full Text] [Related]
10. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.
Mempel M; Ronet C; Suarez F; Gilleron M; Puzo G; Van Kaer L; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2002 Jan; 168(1):365-71. PubMed ID: 11751982
[TBL] [Abstract][Full Text] [Related]
11. Presence of a novel subset of NKT cells bearing an invariant V(alpha)19.1-J(alpha)26 TCR alpha chain.
Shimamura M; Huang YY
FEBS Lett; 2002 Apr; 516(1-3):97-100. PubMed ID: 11959111
[TBL] [Abstract][Full Text] [Related]
12. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
14. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
Xu H; Chun T; Colmone A; Nguyen H; Wang CR
J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
[TBL] [Abstract][Full Text] [Related]
16. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
18. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
19. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
